Cipla plans to file over dozen new drug applications for FY20 Garima27 May 2019 9:30 AM ISTIn another key market of South Africa, during the current fiscal year, Cipla is looking to strengthen its OTC (over-the-counter) business.New Delhi:...
CDSCO Committee rejects proposal for additional Indications of Dapaglofizin Meghna A Singhania5 May 2019 12:52 PM ISTNew Delhi: British-Swedish multinational drugmaker, AstraZeneca's stride to win approval from the Indian drug regulators for the additional...
Glenmark launches SGLT2 Inhibitor Remogliflozin under brand names Remo, Remozen Meghna A Singhania30 April 2019 10:16 AM ISTGlenmark will commercialize Remogliflozin in India under the brand names 'Remo' and 'Remozen'.Mumbai: In a major relief to diabetics, Glenmark...
Patent Infringement: Cadila Healthcare, two others prohibited from launching Linagliptin Metformin Hydrochloride tablets Meghna A Singhania22 April 2019 2:07 PM ISTAHMEDABAD: In a major setback, three Gujarat based pharmaceutical companies including Cadila Healthcare, West Coast Pharmaceutical Works Ltd and Maan...
Amazon Alexa to now help in health care; store BP measurement, book medical appointment, check prescription delivery Medical Dialogues Bureau8 April 2019 9:40 AM ISTAmazon announced that its Alexa-enabled devices can now handle customers' sensitive medical data. A new kit will allow approved developers to build...
Novartis to face lawsuit over doctor kickbacks Garima3 April 2019 9:10 AM ISTThe case began in 2011 as a whistleblower lawsuit filed by Oswald Bilotta, a former Novartis sales representative. Such lawsuits, brought under the...
Diabetes Treatment: CDSCO expert panel marketing authorization Nod to Glenmark's SGLT2 Inhibitor Remogliflozin etabonate Meghna A Singhania31 March 2019 1:39 PM ISTNew Delhi: Mumbai-based Glenmark Pharmaceuticals Limited recently received the permission from the IND Committee of the Central Drugs Standard...
Manufacturers of SGLT2 inhibitor Drugs to have to INCLUDE safety WARNING in package: CDSCO Farhat Nasim26 March 2019 1:28 PM ISTNew Delhi: Paying heed to the safety updates of Sodium-Glucose Cotransporter-2 (SGLT2) including medicines such as Canagliflozin, Dapagliflozin,...
Setback: USFDA rejects Sanofi, Lexicon Sotagliflozin for type 1 diabetes Farhat Nasim24 March 2019 9:45 AM ISTThe decision comes about two months after an FDA advisory panel failed to reach a consensus over whether the once-daily oral drug, sotagliflozin,...
Healthians to expand in South India, invests Rs 50 crore Farhat Nasim13 Jan 2019 9:30 AM IST"Based on our market survey and customer demand, South India is our first move for a mega expansion planned in 2019," Deepak Sahni, Founder and CEO of...
FDA approves Novo Nordisk fast-acting insulin Fiasp Ruby Khatun Khatun4 Oct 2017 9:57 AM ISTThe U.S. Food and Drug Administration (FDA) on Friday approved Novo Nordisk's fast-acting insulin to treat diabetes.The product, known as Fiasp, is...
